Helen Van Hoecke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Helen Van Hoecke has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Ingeborg Dhooge
Ghent University
4 shared publications - An Boudewyns
Department of Otorhinolaryngology Head and Neck Surgery, https://dx.doi.org/99034Antwerp University Hospital, Edegem, Belgium
2 shared publications - David Loose
Department of Otorhinolaryngology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium
2 shared publications - Elise De Cuyper
Department of Head and Skin, Ghent University, Ghent, Belgium
2 shared publications - Els De Leenheer
Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent University, Corneel Heymanslaan 10, Gent, 9000, Belgium; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Ghent, Corneel Heymanslaan 10, Gent, 9000, Belgium
2 shared publications Liesbeth Royackers
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospitals of Leuven, Leuven, Belgium
2 shared publications
Latest Publications
- Open Access
- 1 February 2023
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 149 (2) , 122-130
Risk Factors for Hearing Loss at Birth in Newborns With Congenital Cytomegalovirus Infection
Importance: With a prevalence between 0.2% and 6.1% of all live births, congenital cytomegalovirus (cCMV) infection is a major cause of congenital nonhereditary sensorineural hearing loss. Despite the large amount of research on cCMV-related hearing loss, it is still unclear which newborns are at risk of hearing loss.Objective: To identify independent risk factors for cCMV-related congenital hearing loss and predictors of hearing loss severity at birth.Design, Setting, and Participants: This cross-sectional study of newborns with cCMV infection used data included in the Flemish CMV registry that was collected from 6 secondary and tertiary hospitals in Flanders, Belgium, over 15 years (January 1, 2007, to February 7, 2022). Data were analyzed March 3 to October 19, 2022. Patients were included in the study after confirmed diagnosis of cCMV infection and known hearing status at birth. Patients who presented with other possible causes of sensorineural hearing loss were excluded.Main Outcomes and Measures: Primary outcome was hearing status at birth. Clinical, neurological, and laboratory findings along with the timing of seroconversion and blood viral load were separately considered as risk factors. Binary logistic regression was performed to identify independent risk factors for congenital hearing loss in newborns with cCMV. Effect sizes were measured using Hedgesg, odds ratio, or CramerV.Results: Of the 1033 newborns included in the study (553 of 1024 [54.0%] boys), 416 (40.3%) were diagnosed with symptomatic cCMV infection and 617 (59.7%) with asymptomatic cCMV infection. A total of 15.4% of the patients (n = 159) presented with congenital hearing loss; half of them (n = 80 [50.3%]) had isolated hearing loss. The regression model revealed 3 independent risk factors for congenital hearing loss: petechiae at birth (adjusted odds ratio [aOR], 6.7; 95% CI, 1.9-23.9), periventricular cysts on magnetic resonance imaging (MRI; aOR, 4.6; 95% CI, 1.5-14.1), and seroconversion in the first trimester (aOR, 3.1; 95% CI, 1.1-9.3). Lower viral loads were seen in patients with normal hearing compared with those with congenital hearing loss (median [IQR] viral load, 447.0 [39.3-2345.8] copies per milliliter of sample [copies/mL] vs 1349.5 [234.3-14 393.0] copies/mL; median difference, −397.0 [95% CI, −5058.0 to 174.0] copies/mL).Conclusions and Relevance: Findings of this cross-sectional study suggest that newborns with cCMV infection and petechiae at birth, periventricular cysts on MRI, or a seroconversion in the first trimester had a higher risk of congenital hearing loss. Clinicians may use these risk factors to counsel parents in the prenatal and postnatal periods about the risk of congenital hearing loss. Moreover, linking clinical features to hearing loss may provide new insights into the pathogenesis of cCMV-related hearing loss. The importance of viral load as a risk factor for congenital hearing loss remains unclear.
- 1 February 2023
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 149 (2) , 122-130
Open AccessRisk Factors for Hearing Loss at Birth in Newborns With Congenital Cytomegalovirus Infection
Importance: With a prevalence between 0.2% and 6.1% of all live births, congenital cytomegalovirus (cCMV) infection is a major cause of congenital nonhereditary sensorineural hearing loss. Despite the large amount of research on cCMV-related hearing loss, it is still unclear which newborns are at risk of hearing loss.Objective: To identify independent risk factors for cCMV-related congenital hearing loss and predictors of hearing loss severity at birth.Design, Setting, and Participants: This cross-sectional study of newborns with cCMV infection used data included in the Flemish CMV registry that was collected from 6 secondary and tertiary hospitals in Flanders, Belgium, over 15 years (January 1, 2007, to February 7, 2022). Data were analyzed March 3 to October 19, 2022. Patients were included in the study after confirmed diagnosis of cCMV infection and known hearing status at birth. Patients who presented with other possible causes of sensorineural hearing loss were excluded.Main Outcomes and Measures: Primary outcome was hearing status at birth. Clinical, neurological, and laboratory findings along with the timing of seroconversion and blood viral load were separately considered as risk factors. Binary logistic regression was performed to identify independent risk factors for congenital hearing loss in newborns with cCMV. Effect sizes were measured using Hedgesg, odds ratio, or CramerV.Results: Of the 1033 newborns included in the study (553 of 1024 [54.0%] boys), 416 (40.3%) were diagnosed with symptomatic cCMV infection and 617 (59.7%) with asymptomatic cCMV infection. A total of 15.4% of the patients (n = 159) presented with congenital hearing loss; half of them (n = 80 [50.3%]) had isolated hearing loss. The regression model revealed 3 independent risk factors for congenital hearing loss: petechiae at birth (adjusted odds ratio [aOR], 6.7; 95% CI, 1.9-23.9), periventricular cysts on magnetic resonance imaging (MRI; aOR, 4.6; 95% CI, 1.5-14.1), and seroconversion in the first trimester (aOR, 3.1; 95% CI, 1.1-9.3). Lower viral loads were seen in patients with normal hearing compared with those with congenital hearing loss (median [IQR] viral load, 447.0 [39.3-2345.8] copies per milliliter of sample [copies/mL] vs 1349.5 [234.3-14 393.0] copies/mL; median difference, −397.0 [95% CI, −5058.0 to 174.0] copies/mL).Conclusions and Relevance: Findings of this cross-sectional study suggest that newborns with cCMV infection and petechiae at birth, periventricular cysts on MRI, or a seroconversion in the first trimester had a higher risk of congenital hearing loss. Clinicians may use these risk factors to counsel parents in the prenatal and postnatal periods about the risk of congenital hearing loss. Moreover, linking clinical features to hearing loss may provide new insights into the pathogenesis of cCMV-related hearing loss. The importance of viral load as a risk factor for congenital hearing loss remains unclear.
- Open Access
- 1 November 2021
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 17 (6) , 551-558
Hearing Loss in Malignant Infantile Osteopetrosis: A Case-Based Review
Osteopetrosis, or marble bone disease, is a rare genetic disease of bone resorption. It includes a clinically heterogeneous group of conditions that are characterized by increased bone density on radiographs due to a defect in osteoclasts. A most common feature of osteopetrosis of the temporal bone is hearing impairment. This case-based review describes the potential otologic and hearing manifestations of malignant infantile osteopetrosis. The hearing loss can be conductive, sensorineural, late-onset or relapsing. Once the diagnosis is made, referral to an ENT physician for hearing evaluation is indicated. Although otitis media with effusion is the most frequent cause of conductive hearing loss with autosomal recessive osteopetrotic patients, audiometry after tympanostomy tube placement to check for additional causes of hearing loss is highly recommended. As otological manifestations may worsen over time, accurate and regular follow-up by audiometry is necessary. According to our knowledge, this is the first case report in the literature of dehiscent jugular bulb in a patient with osteopetrosis. Cite this article as: De Cuyper E, De Cuyper C, Willems L, Casselman J, Dhooge I, Van Hoecke H. Hearing loss in malignant infantile osteopetrosis: A case-based review. J Int Adv Otol. 2021;17(6):551-558.
- 1 November 2021
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 17 (6) , 551-558
Open AccessHearing Loss in Malignant Infantile Osteopetrosis: A Case-Based Review
Osteopetrosis, or marble bone disease, is a rare genetic disease of bone resorption. It includes a clinically heterogeneous group of conditions that are characterized by increased bone density on radiographs due to a defect in osteoclasts. A most common feature of osteopetrosis of the temporal bone is hearing impairment. This case-based review describes the potential otologic and hearing manifestations of malignant infantile osteopetrosis. The hearing loss can be conductive, sensorineural, late-onset or relapsing. Once the diagnosis is made, referral to an ENT physician for hearing evaluation is indicated. Although otitis media with effusion is the most frequent cause of conductive hearing loss with autosomal recessive osteopetrotic patients, audiometry after tympanostomy tube placement to check for additional causes of hearing loss is highly recommended. As otological manifestations may worsen over time, accurate and regular follow-up by audiometry is necessary. According to our knowledge, this is the first case report in the literature of dehiscent jugular bulb in a patient with osteopetrosis. Cite this article as: De Cuyper E, De Cuyper C, Willems L, Casselman J, Dhooge I, Van Hoecke H. Hearing loss in malignant infantile osteopetrosis: A case-based review. J Int Adv Otol. 2021;17(6):551-558.
- 16 March 2018
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 275 (5) , 1121
Correction to: Long-term hearing results of stapedotomy: analysis of factors affecting outcome
The given and family names of all the co-authors are incorrect in the published article. The correct names should read as follows:
- 16 March 2018
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 275 (5) , 1121
Correction to: Long-term hearing results of stapedotomy: analysis of factors affecting outcome
The given and family names of all the co-authors are incorrect in the published article. The correct names should read as follows:
- 16 February 2018
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 275 (5) , 1111-1119
Long-term hearing results of stapedotomy: analysis of factors affecting outcome
To evaluate long-term hearing results of stapedotomy and analyze the influence of patient-, disease-, and procedure-related variables.
- 16 February 2018
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 275 (5) , 1111-1119
Long-term hearing results of stapedotomy: analysis of factors affecting outcome
To evaluate long-term hearing results of stapedotomy and analyze the influence of patient-, disease-, and procedure-related variables.
- 1 May 2016
- Published by Elsevier in The Journal of Pediatrics
- Vol. 172, 110-115.e2
Hearing in Children with Congenital Cytomegalovirus Infection: Results of a Longitudinal Study
- 1 May 2016
- Published by Elsevier in The Journal of Pediatrics
- Vol. 172, 110-115.e2
Hearing in Children with Congenital Cytomegalovirus Infection: Results of a Longitudinal Study